Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has requested a trading halt for its securities on the ASX, ahead of an announcement regarding the pricing and allocation of its US initial public offering (IPO) of new American Depositary Shares and their listing on the Nasdaq Global Market. The halt will remain until either the completion of the allocation process is publicly disclosed or trading resumes on June 17, 2024.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
